Third positive pivotal Phase III clinical trial of AstraZeneca’s IL-33-targeting biologic further demonstrates its benefits in COPD Positive high-level results from the pivotal Phase III MIRANDA trial ...
Data analysis conducted in collaboration with a leading academic medical center shows that AI‑Immunology™ enables vaccine design also for the deadly brain cancer, glioblastomaUniquely, the platform ...
Gifts left in wills in the past are helping to shape the cancer research making a difference to patients today.
Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically ...
It's the latest in a long-running dispute over the drugs, which some view as groundbreaking, while others say they leave much ...
Strategic collaboration with a leading global CRO supports disciplined trial execution and operational efficiency, advancing Faron's mission to provide treatment for patients with HR-MDS TURKU, FI / ...
AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint: Cambridge, UK Positive high-level res ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results